Loading...

uniQure N.V.

QURE•NASDAQ
Healthcare
Biotechnology
$22.82
$1.66(7.84%)
U.S. Market opens in 2h 59m

uniQure N.V. (QURE) Stock Overview

Explore uniQure N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-6.88
EPS (TTM)$-3.49
ROE-1.46%
Fundamental Analysis

AI Price Forecasts

1 Month$23.34
3 Months$30.50
1 Year Target$36.67

QURE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of uniQure N.V. (QURE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $36.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.88 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.84%
5-Day Change
14.96%
1-Month Change
31.22%
3-Month Change
-11.03%
6-Month Change
-17.05%
Year-to-Date (YTD) Change
-4.64%
1-Year Change
98.78%
3-Year Change
5.55%
5-Year Change
-30.55%
All-Time (Max) Change
56.19%

Contact Information

https://www.uniqure.com
31 20 240 6000
Paasheuvelweg 25a, Amsterdam, NaN, 1105 BP

Company Facts

209 Employees
IPO DateFeb 5, 2014
CountryNL
Actively Trading

Frequently Asked Questions